Press Releases NeuroPace, Inc.

Equities

NPCE

US6412881053

Market Closed - Nasdaq Other stock markets 01:30:00 14/05/2024 am IST			5-day change	1st Jan Change
8.52 ^USD	+0.24%		-36.75%	-17.36%

13/05	Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating	MT
08/05	NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update	09/05	AQ
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024	18/04	GL
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference	28/03	AQ
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million	06/03	GL
NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024	16/02	AQ
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates	08/01	AQ
NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study	21/12	AQ
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference	20/12	GL
NeuroPace to Leverage the Power of its RNS System's Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration	05/12	AQ
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration	05/12	GL
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society Annual Meeting	04/12	AQ
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting	01/12	GL
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting	01/12	AQ
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference	21/11	GL
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference	21/11	AQ
NeuroPace : November Investor Presentation	07/11	PU
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance	07/11	GL
NeuroPace Announces RNS System Enhancements Designed to Streamline Care	18/23/18	GL
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023	17/23/17	GL
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference	21/23/21	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NeuroPace, Inc.

Equities

NPCE

US6412881053

Press Releases

Filters